Concepedia

Sivaprakasam Mangaleswaran

SM

Statistics

Publications

8

Citations

229

H-Index

8

Active since

2000

Affiliations

National Chemical Laboratory(Current)

Newcastle University

Cancer Research UK

Institute of Cancer Research

Institut Lavoisier de Versailles

Sivaprakasam Mangaleswaran is an author at National Chemical Laboratory specializing in medicinal chemistry, enzyme inhibition, and pharmacology.

Publications per year

2000–2020

8

Publications

8

Cyclin-Dependent Kinase (CDK) Inhibitors: Structure–Activity Relationships and Insights into the CDK-2 Selectivity of 6-Substituted 2-Arylaminopurines

Christopher R. Coxon, Elizabeth Anscombe, Suzannah J. Harnor et al. · Journal of Medicinal Chemistry · 2016 · 119 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

A Straightforward Synthesis of Enantiopure Bicyclic Azetidines

Sivaprakasam Mangaleswaran, François Couty, Olivier David et al. · European Journal of Organic Chemistry · 2007 · 24 citations

Natural Sciences, Chemistry, Medicinal Chemistry +12

2-Arylamino-6-ethynylpurines are cysteine-targeting irreversible inhibitors of Nek2 kinase

Christopher J. Matheson, Christopher R. Coxon, Richard Bayliss et al. · RSC Medicinal Chemistry · 2020 · 18 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

A Facile Synthesis of Naturally Occurring Aminopeptidase Inhibitor Tyromycin A

Sivaprakasam Mangaleswaran, Narshinha P. Argade · The Journal of Organic Chemistry · 2001 · 17 citations

Life Sciences, Biochemistry, Medicinal Chemistry +6

Structure-guided design of purine-based probes for selective Nek2 inhibition

Christopher R. Coxon, Christopher Wong, Richard Bayliss et al. · Oncotarget · 2016 · 16 citations · Full text

Medicine, Oncology, Pharmacology +16

1–5 of 8